Cargando…
TMEPAI/PMEPA1 Is a Positive Regulator of Skeletal Muscle Mass
Inhibition of myostatin- and activin-mediated SMAD2/3 signaling using ligand traps, such as soluble receptors, ligand-targeting propeptides and antibodies, or follistatin can increase skeletal muscle mass in healthy mice and ameliorate wasting in models of cancer cachexia and muscular dystrophy. How...
Autores principales: | Hagg, Adam, Kharoud, Swati, Goodchild, Georgia, Goodman, Craig A., Chen, Justin L., Thomson, Rachel E., Qian, Hongwei, Gregorevic, Paul, Harrison, Craig A., Walton, Kelly L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672205/ https://www.ncbi.nlm.nih.gov/pubmed/33250771 http://dx.doi.org/10.3389/fphys.2020.560225 |
Ejemplares similares
-
SUN-140 TMEPAI Inhibits SMAD 2/3 Mediated Muscle Wasting
por: Kharoud, Swati, et al.
Publicado: (2020) -
TMEPAI/PMEPA1 enhances tumorigenic activities in lung cancer cells
por: Vo Nguyen, Thanh Thao, et al.
Publicado: (2014) -
PMEPA1/TMEPAI Is a Unique Tumorigenic Activator of AKT Promoting Proteasomal Degradation of PHLPP1 in Triple-Negative Breast Cancer Cells
por: Haque, Md. Anwarul, et al.
Publicado: (2021) -
Using AAV vectors expressing the β(2)-adrenoceptor or associated Gα proteins to modulate skeletal muscle mass and muscle fibre size
por: Hagg, Adam, et al.
Publicado: (2016) -
Dynamic Changes to the Skeletal Muscle Proteome and Ubiquitinome Induced by the E3 Ligase, ASB2β
por: Goodman, Craig A., et al.
Publicado: (2021)